4.4 Article

Changes in neurotransmitter levels, brain structural characteristics, and their correlation with PANSS scores in patients with first-episode schizophrenia

Related references

Note: Only part of the references are listed.
Article Psychiatry

Altered central vision and amacrine cells dysfunction as marker of hypodopaminergic activity in treated patients with schizophrenia

Florent Bernardin et al.

Summary: This study found that patients with schizophrenia have retinal dysfunctions, which may be associated with a defect in dopamine transmission. The dysfunctions are characterized by reduced amplitudes in the central area of the retina and decreased oscillatory potentials.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Interactive effects of maintenance decay and interference on working memory updating in schizophrenia

Milena Y. Gotra et al.

Summary: This study found that early encoding of a single item is intact in patients with a schizophrenia spectrum disorder, but information rapidly decays from working memory stores with extended delays. Accuracy further decreases when information is retrieved from working memory, suggesting that working memory stores may also be susceptible to disruption from internal stimuli.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Volume deficits in hippocampal subfields in unaffected relatives of schizophrenia patients with high genetic loading but without any psychiatric symptoms

Sunah Choi et al.

Summary: The study found volume changes in specific subregions of the hippocampus in relatives of schizophrenia patients, suggesting a genetic vulnerability to schizophrenia. Additionally, differences in volume in another subregion between relatives and first-episode psychosis patients may reflect a schizophrenia risk unrelated to genetic vulnerability.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Subtyping Schizophrenia Patients Based on Patterns of Structural Brain Alterations

Yuan Xiao et al.

Summary: The study identified distinct subgroups of schizophrenia patients based on structural brain features, representing important progress for studies of illness neurobiology and potential clinical trials. Using unsupervised cluster analysis, a stable classification pattern of three subgroups was found, with subgroup 1 in midcourse schizophrenia patients showing worse cognitive functions compared to subgroup 3.

SCHIZOPHRENIA BULLETIN (2022)

Article Psychiatry

The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia

Peter E. Clayson et al.

Summary: Deficits in early auditory information processing contribute to cognitive and psychosocial disability. The present study investigated the psychometric properties of the frequency following response (FFR), a potential biomarker of response to auditory-based cognitive training interventions, in schizophrenia patients. The results showed that schizophrenia patients had longer latencies and lower signal-to-noise ratios in most FFR peaks compared to healthy subjects. However, the FFR sustained response demonstrated excellent internal consistency and significant group differences, making it a viable measure for clinical treatment studies.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Identifying strategies to improve PANSS based dimensional models in schizophrenia: Accounting for multilevel structure, Bayesian model and clinical staging

Cinthia H. Higuchi et al.

Summary: This study aimed to compare different CFA methods in order to identify a dimensional PANSS CFA model with good psychometric properties. The results showed that the traditional CFA and Bayesian CFA produced poor fit models, but when a multilevel structure was added to the CFA model, a good fit model emerged. MIMIC modeling also revealed significant differences in the factor structure between clinical stages of schizophrenia. These findings highlight the importance of multilevel structure and staging models in improving the characterization of schizophrenia.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features

Stefano Barlati et al.

Summary: This study assessed the factors associated with self-stigma in individuals diagnosed with schizophrenia, highlighting the importance of subjective medication side effects perception and their impact on internalized stigma.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Going deep into schizophrenia with artificial intelligence

Jose A. Cortes-Briones et al.

Summary: Despite years of research, the mechanisms governing schizophrenia (SZ) remain elusive. Deep learning, a subfield of artificial intelligence, provides a promising approach for modeling and analyzing the complexity of SZ. It has shown unprecedented accuracy in classification and prediction tasks, making it valuable for clinicians in the prediction, diagnosis, and treatment of SZ. However, methodological concerns and the limited clinical value of some models should be taken into consideration.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Neural correlates of disturbance in the sense of agency in schizophrenia: An fMRI study using the 'enfacement' paradigm

Pilar Salgado-Pineda et al.

Summary: The study examines the brain correlates of agency in schizophrenia using the enfacement illusion paradigm. It reveals decreased activation in the left temporoparietal junction (TPJ) in schizophrenia patients, which is associated with poorer insight.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Early Intervention Services for Schizophrenia: Looking Back and Looking Ahead

Vinod H. Srihari et al.

Summary: This article provides a conceptual history of modern early intervention services and briefly reviews the accomplishments of an international clinical and research community. It also offers proposals for how such services can participate in the next generation of progress, emphasizing the importance of bi-directional knowledge translation across basic, clinical, and policy domains.

SCHIZOPHRENIA BULLETIN (2022)

Review Psychiatry

Healthcare costs and resource use associated with negative symptoms of schizophrenia: A systematic literature review

Sharon Weber et al.

Summary: This study aims to investigate the economic burden associated with negative symptoms of schizophrenia. Through searching and analyzing relevant literature, it is found that there is a positive relationship between negative symptoms and healthcare costs and resource utilization in patients. It should be noted that the cost variation associated with negative symptoms is wide, depending on factors such as patient characteristics, included costs, and country of study.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

The trajectories and correlates of two negative symptom subdomains in first-episode schizophrenia

Lebogang Phahladira et al.

Summary: This study replicated the two-factor structure for PANSS negative symptom subdomains in schizophrenia and found that they are closely related and respond similarly to antipsychotic treatment. The experiential subdomain is affected by depression, while the expressive subdomain is affected by extrapyramidal symptoms.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia

Miquel Bioque et al.

Summary: Relapses are common in the early years following a first episode of schizophrenia, and are associated with higher antipsychotic doses, polypharmacy, benzodiazepine use, side effects reports, psychological treatment, and cannabis consumption.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Sex and gender associations with indicators of neurodevelopmental compromise in schizophrenia spectrum disorders

Hilmar Klaus Luckhoff et al.

Summary: This study examined the associations of biological sex and gender role endorsement with indicators of neurodevelopmental compromise in patients with schizophrenia. The findings showed that lower masculinity scores were significantly correlated with poorer premorbid adjustment, sensory integration deficits, and worse overall cognitive performance. Gender, on the other hand, showed different associations with indicators of neurodevelopmental compromise compared to biological sex.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Changes in emotion processing and social cognition with auditory versus visual neuroscience-informed cognitive training in individuals with schizophrenia

Linda Scoriels et al.

Summary: This study compared the efficacy of auditory and visual neuroscience-informed cognitive training on emotion processing and social cognition in individuals with schizophrenia. Both auditory and visual training were effective at improving emotion processing and social cognition, with the auditory training group showing more remarkable improvement. The improvements were related to cognitive improvement, not symptom improvement.

SCHIZOPHRENIA RESEARCH (2022)

Editorial Material Psychiatry

Reframing schizophrenia: Altering our perceptions?

Gin S. Malhi et al.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Influence of positive and negative symptoms on hedonic and eudaemonic well-being in people with schizophrenia: A longitudinal analysis from the EuroSc study

Giuseppe Carra et al.

Summary: Subjective well-being in people with schizophrenia is influenced by positive and negative symptoms. Positive symptoms have a greater impact on hedonic well-being, while negative symptoms are linked to eudaemonic well-being.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

The Cognitive Assessment Interview (CAI): Association with neuropsychological scores and real-life functioning in a large sample of Italian subjects with schizophrenia

Giulia M. Giordano et al.

Summary: This study investigated the relationships between the Cognitive Assessment Interview (CAI) and measures of cognitive performance, functional capacity, and real-life functioning in a large sample of schizophrenia patients. The results showed that the CAI has good inter-rater reliability and internal consistency, and is a valid instrument for screening impairment in neurocognitive and social cognitive domains and its impact on functioning in schizophrenia patients.

SCHIZOPHRENIA RESEARCH (2022)

Article Clinical Neurology

Event-related potential correlates of affective response inhibition in bipolar I disorder: Comparison with schizophrenia

Margo W. Menkes et al.

Summary: This study aimed to investigate the impaired impulsivity control in individuals with bipolar I disorder (BD) and whether similar difficulties are present in schizophrenia spectrum disorders (SZ). The results suggest that both BD and SZ patients have difficulties in discriminating emotional faces from neutral faces, which may contribute to difficulties in appropriate behavioral responding in social-affective contexts.

JOURNAL OF AFFECTIVE DISORDERS (2022)

Article Psychiatry

The role of the gut microbiome in the development of schizophrenia

John R. Kelly et al.

Summary: Schizophrenia is a complex neurodevelopmental disorder influenced by both genetic and environmental factors. Precise regulation of neural circuitry development and microbiota-gut-brain axis signaling play crucial roles in cognitive and emotional functions. Understanding these mechanisms may lead to potential translational interventions in managing schizophrenia.

SCHIZOPHRENIA RESEARCH (2021)

Article Psychiatry

A comparison of stages of attention for social and nonsocial stimuli in schizophrenia: An ERP study

Lauren T. Catalano et al.

Summary: The study found that patients with schizophrenia exhibit impaired sustained attention for both social and nonsocial stimuli, and their attention may not correspond with their behavior.

SCHIZOPHRENIA RESEARCH (2021)

Review Psychiatry

Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: A systematic review of the guidelines and algorithms

Yutaro Shimomura et al.

Summary: Current guidelines and algorithms recommend increasing antipsychotic dose and switching to another antipsychotic, particularly clozapine, for treatment-resistant schizophrenia during the acute phase.

SCHIZOPHRENIA RESEARCH (2021)

Article Psychiatry

Unraveling the role of retrieval deficits in autobiographical memory impairment in schizophrenia: A comparison of involuntary and voluntary autobiographical memories

Melissa C. Alle et al.

Summary: Patients with schizophrenia exhibit severe autobiographical memory impairment, with both involuntary and voluntary memories similarly affected. This suggests that the impairment is not due to self-initiated retrieval issues, but rather likely reflects encoding or binding deficits.

SCHIZOPHRENIA RESEARCH (2021)

Review Psychiatry

Short-acting intramuscular second-generation antipsychotic drugs for acutely agitated patients with schizophrenia spectrum disorders. A systematic review and network meta-analysis

Giulia Paris et al.

Summary: This network meta-analysis evaluated the efficacy of short-acting IM second-generation antipsychotic drugs in patients with schizophrenia and schizophrenia-like disorders presenting acute agitation. The results showed that ziprasidone, olanzapine, aripiprazole, and haloperidol were more effective than placebo in calming patients at 2 hours. Olanzapine was somewhat more efficacious than aripiprazole.

SCHIZOPHRENIA RESEARCH (2021)

Review Psychiatry

The impact of study design on schizophrenia incidence estimates: A systematic review of Northern European studies 2008-2019

Simon J. Hogerzeil et al.

Summary: Variability in estimates of schizophrenia incidence rates can be largely explained by differences in study design factors. Factors such as time frame for diagnosis and diagnostic quality have a significant impact on reported incidence rates. Understanding and controlling for these study design factors is important when comparing incidence rates between different populations.

SCHIZOPHRENIA RESEARCH (2021)

Review Psychiatry

Advanced paternal age and risk of schizophrenia in offspring - Review of epidemiological findings and potential mechanisms

Vahe Khachadourian et al.

Summary: Studies have shown a link between advanced paternal age and the risk of schizophrenia in offspring, with potential mechanisms including paternal psychiatric morbidity and genetic liability, maternal factors, and findings from family design studies. Multiple mechanisms, including causal and non-causal pathways, contribute to the observed relationship between advanced paternal age and schizophrenia in offspring, highlighting the need for multi-disciplinary studies to unravel these complex and non-mutually exclusive mechanisms.

SCHIZOPHRENIA RESEARCH (2021)

Article Psychiatry

Molecular signaling pathways underlying schizophrenia

Jari Tiihonen et al.

Summary: The molecular pathophysiological mechanisms underlying schizophrenia have remained unknown, but analysis of two different datasets revealed the significant roles of glutamate receptor signaling, hepatic fibrosis, and glycoprotein 6 (GP6) pathways. Additionally, genes such as ADCYAP1, ADAMTS, and CACNA were found to be involved in distinguishing patients from controls in both datasets.

SCHIZOPHRENIA RESEARCH (2021)

Article Psychiatry

Predictors of clozapine discontinuation at 2 years in treatment-resistant schizophrenia

Barbara Iruretagoyena et al.

Summary: This study aimed to identify predictors of clinical response to clozapine in patients with treatment-resistant psychosis. Results showed that older age at clozapine initiation, longer delay from schizophrenia diagnosis to clozapine initiation, and homelessness were associated with higher clozapine non-adherence. Starting clozapine treatment in younger patients or shortly after schizophrenia diagnosis was linked to better adherence.

SCHIZOPHRENIA RESEARCH (2021)

Article Psychiatry

Cognitive outcomes after tDCS in schizophrenia patients with prominent negative symptoms: Results from the placebo-controlled STARTS trial

Lucia Bulubas et al.

Summary: The study found that transcranial direct current stimulation (tDCS) did not effectively improve cognitive function in patients with schizophrenia, and sham-tDCS performed better in some tests. This suggests that modifications to the tDCS treatment protocol may be needed to enhance its effects on cognition.

SCHIZOPHRENIA RESEARCH (2021)

Article Psychiatry

The proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia

Karin E. Borgmann-Winter et al.

SCHIZOPHRENIA RESEARCH (2020)